Posted inGastroenterology news
Identifying Preclinical Crohn’s Disease in High-Risk Individuals Using Faecal Calprotectin: A New Framework for Prevention Trials
A study in asymptomatic first-degree relatives of Crohn's disease patients defines preclinical stages using faecal calprotectin, offering a targeted screening approach to enrich prevention trial cohorts.

